NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

AnphA.00332.a: 50S ribosomal protein L1

Target Characteristics

from organism: Anaplasma phagocytophilum HZ
most recent status: crystallized
center reference id: AnphA.00332.a
is community request: False
associated disease: Human granulocytic anaplasmosis
NIH risk group: 1
is select agent: False
NIH priority
pathogens category:
I

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
AnphA.00332.a.A1.GE26629 Full length( AnphA.00332.a ) 1 216 GE26629
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

Proteins

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
AnphA.00332.a.A1.PS00244 Full length( AnphA.00332.a ) 1 216

External Resources

Resource Reference ID
OrthoMCL: OG5_127255
PATRIC ID: fig|212042.8.peg.1102
RefSeq: YP_505586.1
UniProt: Q2GJ65

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MLDKNIVYTP EEGIDQLLKS TTARFKESVD VAIKLSTGDS RSGDSIRGVA VLPKGLGREV RVAVLAKGEY AKQAKDAGAD VVGDSDLIEE IKKGRKLDFD WCIATPDFMS QVSAIAKILG PRGLMPNPKF GTVTFDIAKM VGIVKSGQVR FRSDKYGIVH VKIGDVGFSR EDLMENLRAV VSAVQGLKPA TVKGAFFKAV FLNSTMGKSF RITGLG

NT Sequence
ATGTTGGATA AGAATATTGT CTATACTCCA GAAGAGGGTA TTGATCAGCT TTTGAAGTCT ACGACTGCTC GTTTTAAGGA ATCGGTGGAT GTAGCGATTA AGCTTTCTAC TGGTGATTCA AGGTCTGGTG ACTCGATAAG GGGAGTTGCT GTATTGCCCA AGGGGCTGGG TAGAGAGGTT AGAGTGGCTG TTTTAGCTAA GGGTGAGTAT GCTAAGCAGG CGAAGGATGC GGGTGCTGAT GTTGTTGGAG ACTCTGATTT AATAGAAGAA ATAAAGAAGG GGCGCAAACT TGATTTTGAT TGGTGTATTG CTACCCCGGA TTTTATGTCG CAGGTTTCTG CGATCGCTAA AATTTTGGGT CCAAGGGGGC TGATGCCTAA TCCGAAGTTC GGTACGGTTA CCTTTGATAT TGCCAAGATG GTTGGTATCG TGAAGTCTGG TCAGGTGAGA TTTAGATCTG ATAAGTATGG TATTGTTCAC GTGAAGATCG GGGATGTGGG ATTTTCTCGT GAGGACTTGA TGGAGAATCT TCGGGCTGTG GTTTCTGCTG TGCAAGGGCT GAAGCCTGCT ACGGTTAAGG GTGCTTTCTT TAAGGCTGTG TTCCTGAATT CTACCATGGG TAAGTCTTTT AGAATAACTG GATTGGGT

© 2019 Center for Infectious Disease Research. All rights reserved. Contact ssgcid@cidresearch.org with questions or feedback.